Search research articles
Contact Us
Filters
Showing results (141-150 of 156) with videos related to
Page
of 16
Sort By:
Oncotarget
|
May 14, 2015
The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1
Chunyan Wang, Zhi Nie, Zhongmei Zhou, et al.
Breast (Edinburgh, Scotland)
|
June 3, 2026
Real-world use of neratinib as extended adjuvant therapy in HER2-positive early-stage breast cancer: a multicentre study in mainland China and Hong Kong
Nilupai Abudureheiyimu, Yueran Jia, Zexi Peng, et al.
Neurosurgical Review
|
December 28, 2024
Brain tumor and mood disorders: a retrospective analysis of anxiety and depression in patients with primary and metastatic brain tumors
Xiaoman Kang, Yulu Ge, Xin Zhang, et al.
Frontiers in Neurology
|
June 5, 2023
An online survival predictor in glioma patients using machine learning based on WHO CNS5 data
Liguo Ye, Lingui Gu, Zhiyao Zheng, et al.
Cancer Medicine
|
July 6, 2024
Clinical features, MRI, molecular alternations, and prognosis of astrocytoma based on WHO 2021 classification of central nervous system tumors: A single-center retrospective study
Yuekun Wang, Hao Xing, Xiaopeng Guo, et al.
Acta Pharmaceutica Sinica. B
|
June 1, 2022
Anticarin-<i>β</i> shows a promising anti-osteosarcoma effect by specifically inhibiting CCT4 to impair proteostasis
Gan Wang, Min Zhang, Ping Meng, et al.
Frontiers in Neuroscience
|
May 22, 2023
Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors
Wenlin Chen, Shanmu Jin, Qianshu Liu, et al.
Cancer Medicine
|
September 5, 2023
Novel insight into histological and molecular astrocytoma, IDH-mutant, Grade 4 by the updated WHO classification of central nervous system tumors
Wenlin Chen, Siying Guo, Yaning Wang, et al.
Frontiers in Oncology
|
March 31, 2023
Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors
Xiaopeng Guo, Yixin Shi, Delin Liu, et al.
International Journal of Surgery (London, England)
|
October 7, 2025
Efficacy, safety and biomarkers of neoadjuvant trastuzumab and pertuzumab combined with chemotherapy in Chinese patients with HER2-positive breast cancer: a multi-center retrospective cohort study
Xiaowei Qi, Hong Hu, Pengfei Qiu, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 156) with videos related to
Sort By:
Page
of 16
Oncotarget
|
May 14, 2015
The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1
Chunyan Wang, Zhi Nie, Zhongmei Zhou, et al.
Breast (Edinburgh, Scotland)
|
June 3, 2026
Real-world use of neratinib as extended adjuvant therapy in HER2-positive early-stage breast cancer: a multicentre study in mainland China and Hong Kong
Nilupai Abudureheiyimu, Yueran Jia, Zexi Peng, et al.
Neurosurgical Review
|
December 28, 2024
Brain tumor and mood disorders: a retrospective analysis of anxiety and depression in patients with primary and metastatic brain tumors
Xiaoman Kang, Yulu Ge, Xin Zhang, et al.
Frontiers in Neurology
|
June 5, 2023
An online survival predictor in glioma patients using machine learning based on WHO CNS5 data
Liguo Ye, Lingui Gu, Zhiyao Zheng, et al.
Cancer Medicine
|
July 6, 2024
Clinical features, MRI, molecular alternations, and prognosis of astrocytoma based on WHO 2021 classification of central nervous system tumors: A single-center retrospective study
Yuekun Wang, Hao Xing, Xiaopeng Guo, et al.
Acta Pharmaceutica Sinica. B
|
June 1, 2022
Anticarin-<i>β</i> shows a promising anti-osteosarcoma effect by specifically inhibiting CCT4 to impair proteostasis
Gan Wang, Min Zhang, Ping Meng, et al.
Frontiers in Neuroscience
|
May 22, 2023
Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors
Wenlin Chen, Shanmu Jin, Qianshu Liu, et al.
Cancer Medicine
|
September 5, 2023
Novel insight into histological and molecular astrocytoma, IDH-mutant, Grade 4 by the updated WHO classification of central nervous system tumors
Wenlin Chen, Siying Guo, Yaning Wang, et al.
Frontiers in Oncology
|
March 31, 2023
Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors
Xiaopeng Guo, Yixin Shi, Delin Liu, et al.
International Journal of Surgery (London, England)
|
October 7, 2025
Efficacy, safety and biomarkers of neoadjuvant trastuzumab and pertuzumab combined with chemotherapy in Chinese patients with HER2-positive breast cancer: a multi-center retrospective cohort study
Xiaowei Qi, Hong Hu, Pengfei Qiu, et al.
Page
of 16